Novan, Inc. is a clinical-stage biotechnology company focused on leveraging nitric oxides natural antiviral and immunomodulatory mechanisms of action to treat dermatological and oncovirus-mediated diseases.
Last Closing Price
January 5, 2018
To view the prospectus for Novan, Inc., or any offering listed on ClickIPO,
download the ClickIPO app...
or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277